Andlauer Healthcare Group (TSE:AND – Get Free Report) had its target price raised by Scotiabank from C$43.00 to C$44.00 in a research note issued on Thursday,BayStreet.CA reports. Scotiabank’s target price would suggest a potential upside of 2.33% from the company’s previous close.
Other analysts have also issued reports about the stock. Eight Capital reduced their price objective on shares of Andlauer Healthcare Group from C$58.00 to C$51.00 and set a “buy” rating for the company in a research note on Friday, August 2nd. Royal Bank of Canada raised their price target on shares of Andlauer Healthcare Group from C$41.00 to C$42.00 and gave the company a “sector perform” rating in a research report on Friday, August 2nd. Finally, TD Securities upped their price objective on Andlauer Healthcare Group from C$53.00 to C$54.00 and gave the company a “buy” rating in a research report on Thursday. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of C$48.57.
Get Our Latest Stock Analysis on AND
Andlauer Healthcare Group Trading Down 4.3 %
About Andlauer Healthcare Group
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
See Also
- Five stocks we like better than Andlauer Healthcare Group
- What Does a Stock Split Mean?
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- What is Forex and How Does it Work?
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- What is Put Option Volume?
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.